Millennium Pharmaceuticals sues MSN Laboratories over cancer drug

22-12-2016

Millennium Pharmaceuticals, now known as Takeda Oncology, has filed a complaint against US-based MSN Laboratories for patent infringement of Velcade (bortezomib), a treatment for cancer.


ANDA, FDA, patent, Velcade, cancer, Millennium Pharmaceuticals, MSN Laboratories

LSIPR